KAUST and Industrial Clusters (IC) virtually signed a Memorandum of Understanding (MoU) to host a National BioPark project in the KAUST Research and Technology Park (KRTP). The BioPark aims to foster research and technology development in biopharmaceutical, smart health, and associated AI technologies. KAUST will provide BioPark entrepreneurs and investors access to its innovation ecosystem and facilities. Why it matters: This initiative will advance Saudi Arabia's biopharmaceutical industry and align with KAUST's focus on biological sciences, smart health, and AI, contributing to economic diversification.
KAUST and King Saud University (KSU) have signed a memorandum of understanding (MoU) to expand cooperation in education, research, training, and professional development. The MoU focuses on launching joint training programs, workshops, and scientific conferences, as well as sharing access to advanced laboratories and research facilities. The partnership aims to strengthen intellectual property management and commercialize research outputs into impactful industrial applications. Why it matters: The agreement signifies a strategic effort to unify research, empower national talent, and translate knowledge into practical applications, supporting Saudi Vision 2030.
KAUST's Industry Collaboration Program (KICP) held its 16th Industry Advisory Board meeting, adding the Ministry of Health, GADD, KFSRC, and NEOM as new members. Since 2009, KICP has enabled $250 million in research funding and provided $138 million in consultancy services, hiring 426 KAUST students. KICP also announced a new three-year agreement with KACARE to expand joint research in energy, sustainability, and advanced systems and research projects with GADD. Why it matters: The expansion of KICP underscores KAUST's role in aligning research with Saudi Arabia's Vision 2030 by fostering collaboration between academia, government, and industry.
KAUST will host the Asian Science Park Association (ASPA) Conference in November 2026. The conference will be held at the KAUST Research and Technology Park (KRTP). The event aims to promote scientific and industrial technologies and economic growth across Asia. Why it matters: This event further positions Saudi Arabia as a hub for innovation and collaboration between the Middle East and Asia, aligning with Saudi Vision 2030's goals for entrepreneurship.
The Research Products Development Company (RPDC) signed an agreement with The Saudi Vaccine and Biomanufacturing Center (SVBC) to establish a research and industrial center in Saudi Arabia for vaccine and biopharmaceutical development. Supported by KACST and hosted by KAUST, the SVBC will provide a state-of-the-art facility and a training platform. Cooperation agreements were also signed with GE for equipment supply and with Fujifilm Dayosent Biotechnology for MERS-CoV treatment development. Why it matters: This initiative aims to localize vaccine and advanced treatment industries in Saudi Arabia, create technical jobs, and reduce reliance on imports in line with Vision 2030.